04, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
Mechanisms Behind GLP-1 Induced Weight Loss
Balansen efter maten frbttras ingen mer dsighet eller energidippar
One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick
Dosage information: At what concentrations are the botanical actives present, and how do those compare to amounts used in published research
GLP-3 RT (RETATRUTIDE) PEN GLP-3 RT (Retatrutide) 10mg / 3mL Pre-Filled Research Pen contains 10mg of Retatrutide in 3mL of sterile solution